The “Weekend Effect” in Cardiac Emergency Outcomes
Saraschandra Vallabhajosyula, MD, and Ibrahim Sultan, MD, discuss the relationship between the weekend effect and poor prognosis following cardiac emergencies.
Saraschandra Vallabhajosyula, MD, and Ibrahim Sultan, MD, discuss the relationship between the weekend effect and poor prognosis following cardiac emergencies.
Maryann A. McLaughlin, MD, and Gregory M. Marcus, MD, discuss the effect of alcohol consumption on risk for atrial fibrillation.
Eugene C. DePasquale, MD, and Erin D. Michos, MD, discuss the effect of mental health on outcomes for patients who have had an acute myocardial infarction.
A look into the growing number of cases of stress cardiomyopathy, also known as Takotsubo syndrome, that have been observed during the COVID-19 pandemic.
Experts discuss the role of the gut microbiome in health inequities and offer suggestions for improving these disparities within research and policy.
Radmila Lyubarova, MD, and Michael G. Nanna, MD, discuss the lack of awareness regarding risk for ASCVD in women and disparities in treatment that they face.
Elizabeth Profita, MD, and Gerard J. Boyle, MD, FACC, discuss myocarditis in younger populations and how pediatric cardiologists should respond with treatment.
In a Q&A, Asher Schranz, MD, MPH, discusses the importance of physician collaboration in the treatment of patients with drug use-associated infective endocarditis.
Anum Minhas, MD, and Jason Vaught, MD, discuss the need to address valvular diseases during pregnancy and how a strong collaboration between obstetricians and cardiologists can help.
Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.